Blue Trust Inc’s Mesoblast MESO Stock Holding History

Blue Trust Inc’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.6K	Hold	1,002	–	–	﹤0.01%	1774
2026 Q1	$15.4K	Buy	+1,002	New	+$16.7K	﹤0.01%	1719
2024 Q4	–	Sell	-146	Closed	-$994	–	2762
2024 Q3	$994	Buy	146 +101	+224%	+$686	﹤0.01%	2700
2024 Q2	$225	Buy	+45	New	+$308	﹤0.01%	2660
2024 Q1	–	Sell	-582	Closed	-$1K	–	2513
2023 Q4	$1K	Buy	+582	New	+$1.39K	﹤0.01%	2361
2023 Q3	–	Sell	-8	Closed	–	–	2191
2023 Q2	$0	Sell	8 -123	-94%	-$879	﹤0.01%	2328
2023 Q1	$1K	Sell	131 -397	-75%	-$2.63K	﹤0.01%	2174
2022 Q4	$3K	Buy	528 +128	+32%	+$800	﹤0.01%	1855
2022 Q3	$2K	Buy	+400	New	+$2.42K	﹤0.01%	1802

Other funds holding MESO

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Blue Trust Inc's MESO Position: Q2 2026 in Review

Blue Trust Inc held its Mesoblast (MESO) position steady in Q2 2026 at 1,002 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1774.

Blue Trust Inc first reported a position in MESO in Q3 2022 and has held it in 9 quarters since. The position peaked at $15.4K in Q1 2026. 4 funds tracked by Wall St. Rank hold MESO as of Q2 2026.

Blue Trust Inc held 1,002 shares of Mesoblast worth $13.6K as of Q2 2026.
Blue Trust Inc left its Mesoblast share count unchanged in Q2 2026.
Mesoblast made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1774 holding.
Blue Trust Inc first reported a position in Mesoblast in Q3 2022 and has held it in 9 quarters since.
Blue Trust Inc's Mesoblast position peaked at $15.4K in Q1 2026.
4 funds tracked by Wall St. Rank held Mesoblast as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.